Symptoms of Coxsackievirus B5 Infection in Pregnancy
Coxsackievirus B5 infection during pregnancy typically presents as an undifferentiated febrile illness or aseptic meningitis in the mother, often with minimal or subclinical symptoms, while posing significant risks to the neonate rather than causing obvious maternal disease.
Maternal Clinical Manifestations
The maternal presentation of Coxsackievirus B5 infection is often deceptively mild:
- Febrile illness - undifferentiated fever without specific localizing symptoms 1
- Aseptic meningitis - headache, fever, neck stiffness, and altered mental status 2
- Subclinical or minimal symptoms - many infections produce no obvious maternal illness despite active viral replication 3
A critical pitfall: The mother may appear relatively well while harboring significant viral loads that can be transmitted to the fetus or neonate. In one study, Coxsackievirus B5 was recovered from the cervix and throat in four of five infected third-trimester women, and from the rectum in three, despite minimal maternal symptoms 1.
Timing and Severity Considerations
Third trimester infections carry the highest risk, particularly for neonatal transmission. The virus demonstrates cervical carriage or infection in the last trimester, creating a direct transmission route during vaginal delivery 1. While maternal symptoms may be mild, the consequences for the neonate can be severe.
Fetal and Neonatal Consequences
Though you asked about maternal symptoms, understanding the fetal/neonatal risks is essential for clinical decision-making:
- Neonatal disease ranges from inapparent infection to fulminant systemic illness with potential mortality 3, 4
- Common neonatal syndromes include: myocarditis, meningoencephalitis, pneumonia, hepatitis, and systemic disease 4, 5
- Congenital malformations: Increased risk of congenital heart defects (particularly ventricular septal defects and non-compaction of ventricular myocardium) and urogenital anomalies 6, 7
- Pregnancy loss: Potential for increased early spontaneous abortions, stillbirths late in pregnancy, and fetal death 3, 6, 8
Transmission Routes
Understanding transmission helps identify at-risk pregnancies:
- Vertical transmission occurs in 30-50% of maternal infections 4
- Routes include: transplacental passage, contact with maternal cervical secretions during vaginal delivery, blood, respiratory secretions, and postnatal exposure 4, 8
- Cervical viral shedding is common in infected third-trimester women, even when asymptomatic 1
Clinical Recognition Strategy
When to suspect Coxsackievirus B5 in pregnancy:
- Any febrile illness in third trimester, especially during summer/fall months when enteroviruses peak
- Aseptic meningitis presentation (fever, headache, neck stiffness) 2
- Minimal or absent symptoms in a woman who delivers an infant with unexplained systemic illness, myocarditis, or meningoencephalitis
- Community outbreaks of enteroviral disease coinciding with pregnancy
Diagnostic Approach
- Viral culture from throat, cervix, and rectum can identify active infection 1
- RT-PCR from maternal samples provides rapid diagnosis 5
- Serologic testing for seroconversion may be helpful but less practical in acute settings
Key Clinical Caveat
The disconnect between mild maternal symptoms and severe neonatal disease is the most dangerous aspect of Coxsackievirus B5 infection in pregnancy. Clinicians must maintain high suspicion for enteroviral infection in any febrile pregnant woman, particularly in the third trimester, and implement appropriate infection control measures to prevent neonatal transmission 2, 3. Isolation of infected individuals and prevention strategies are the mainstays of management, as specific antiviral therapies remain limited to supportive care 3, 5.